ALK and lung adenocarcinoma: Notably, mutations in ALK and PTEN are concordant in a range of tumor types, including lung adenocarcinoma, endometrial cancer, colorectal cancer, and triple‐negative breast cancer [15, 16, 17, 18, 19].